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Summary 
 
Parkinson’s disease has long been associated with 
Lewy Bodies composed of the protein α-synuclein.  
A groundbreaking new study has demonstrated the 
pathological function of α-synuclein may be 
impairment of ER-Golgi traffic. 
 
Introduction 
 
Parkinson’s disease (PD) is a fatal neurodegenerative 
disorder of the brain.  It affects 1 in 100 individuals over 
the age of 60 of which 5-10% of cases occur in 
individuals under 40, and another ~5-10% are familial 
(NPF, 2006).  PD is the result of neuronal atrophy 
within the substantia nigra located in the brain stem.  
The substantia nigra is part of a complex circuit called 
the basal ganglia.  It is responsible for the initiation of 
movement (Purves et al., 2004).  The hallmark feature 
of PD is neurofibrillary inclusions, Lewy Bodies, 
composed primarily of the protein α-synuclein (αSyn; 
Spillantini et al., 1998).  Familial forms of PD have been 
linked to the αSyn mutations A30P (Krueger et al., 
1998), A53T (Polymeropoulos et al., 1997), and 
recently E46K (Zarranz et al., 2004).  However, the 
reason these cells are dying in PD patients remains 
unknown even after more than a decade of heavily 
funded research!   
 αSyn’s pathological component has often 
been associated with its role in Lewy Bodies.  One 
widely accepted hypothesis is that αSyn is pathological 
when in a protofibrillar form that occurs between 
monomeric αSyn disappearance and Lewy Body 
appearance (Lansbury et al., 2003).  However, a 
remarkable new manuscript, “α-Synuclein Blocks ER-
Golgi Traffic and Rab1 Rescues Neuron Loss in 
Parkinson’s Models”, by Lindquist et al. (2006) has 
demonstrated that the pathogenicity of αSyn may be 
due to the impairment of ER-Golgi traffic, resulting in a 
halt of critical cellular secretory processes.   
 Prior to their research, little was known about 
α-Syn’s relationship with the ER-Golgi pathway.  
However, αSyn expression led to the fragmentation of 
the Golgi apparatus (Fujita et al., 2006 and Gosavi et 
al., 2002).  Notably, Gosavi et al. (2002) found Golgi 
fragmentation to occur before Lewy Body formation but 
after the disappearance of monomeric αSyn.  Contrary 
to the αSyn-Golgi interaction, Lee et al. (2005) revealed 
αSyn to be excreted from the cell via a vesicular, ER-
Golgi independent, exocytotic pathway.  Thus, debate 
exists over which pathway αSyn is involved in.  
 
The Case of the Blocked ER-Golgi Pathway 
 
In the recent Lindquist et al. (2006) study, they wanted 
to determine the effect of αSyn on the ER-Golgi  
 
*This paper was written for BIOL 493 Independent Study taught by Dr. 
Shubhik K. DebBurman. 
 
 
pathway.  In order to accomplish this task, they took 
two approaches; one genetic and the other cellular.  
Together these different pathways would converge to 
implicate αSyn in the blocking of ER-Golgi traffic and 
cell death. 
  αSyn was expressed in yeast and regulated 
with a galactose inducible promoter.  After αSyn 
expression, ER stress was measured and found to be 
increased for cells expressing αSyn-WT and further 
increased for the familial mutant αSyn-A53T.  Lindquist 
et al. (2006) hypothesized that αSyn was causing ER 
stress by blocking the function of endoplasmic reticulum 
associated degradation (ERAD).  As misfolded proteins 
accumulate in the ER, the ERAD process functions by 
retrotranslocating them back into the cytoplasm for 
proteasomal degradation (McCracken and Bdodsky 
2006).  They found that out of two commonly misfolded 
proteins in the ER, CPY and Sec61-2p (both ERAD 
substrates), the rate of CPY degradation decreased 
even though proteasomal function was unaltered.  
Interestingly, Caldwell et al. (2001) demonstrated that 
ERAD degradation of CPY required transport through 
the Golgi. 
 Because the failure of the ERAD 
translocation through the ER to the Golgi during αSyn 
expression may be an indicator of general pathway 
blockage, Lindquist et al. (2006) hypothesized that 
αSyn may be blocking ER-Golgi traffic.  To determine if 
this was the case, they followed two proteins, CPY and 
ALP, through the ER-Golgi circuit when αSyn was 
expressed.  Within three hours, ER-Golgi traffic was 
greatly reduced and at four hours nearly nonexistent.  
Simultaneously, cell growth inhibition also occurred.  
Thus, αSyn blocks ER-Golgi traffic (2006). 
Following their cellular approach, Lindquist et 
al. (2006) initiated a genetics approach aimed at 
determining if genes that enhance ER-Golgi transport 
could reduce αSyn’s ability to block the pathway.  They 
identified the yeast protein Ypt1p as a promoter of 
traffic, and Gyp8P as a suppresser of traffic.  This 
finding led Lindquist et al. (2006) to hypothesize that 
over-expression of the Ypt1p (yeast) or Rab1 
(mammalian) in a variety of models would rescue them 
from αSyn toxicity. 
 This final study yielded profound results that 
provided the strongest evidence, yet, that αSyn’s 
impairment of ER-Golgi traffic was the source for 
toxicity.  They overexpressed Rab1 along with αSyn in 
Drosophila melanogaster (fruit fly), C. elegans (worm), 
and mammalian dopaminergic neurons to determine if 
Rab1 would prevent αSyn toxicity by enhancing ER-
Golgi traffic.  In all three models, the cells were rescued 
from death when overexpressing Rab1. 
 As a result of Ypt1p/Rab1 re-establishing ER-
Golgi traffic, it was hypothesized that αSyn interacted at 
the ER-Golgi junction.  This was based on two lines of 
evidence; 1) CSP requires transport into the Golgi to be 
degraded and 2) Ypt1p/Rab1 functions within the ER-
Golgi vesicular binding pathway.  Therefore, when 
Ypt1P/Rab1 is over-expressed, vesicular binding 
efficiency increases. 
 Returning to the Gosavi et al. (2002) and Lee 
et al. (2005) manuscripts, the Lindquist et al. (2006) 
data provides two established lines of evidence (i.e. 
detailed previously) supporting the Gosavi et al. (2002) 
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conclusion that αSyn interacts with the ER-Golgi to 
yield toxicity.  Though αSyn is continuously being 
secreted through a Golgi-ER independent pathway (Lee 
et al., 2005), it is plausible that a defect in this excretory 
system may function to exacerbate toxicity, but not 
produce it. 
 
Future Research 
 
The Lindquist et al. (2006) manuscript has provided the 
Parkinson’s disease community with what appears to 
be an opened door, leading to a whole new frontier in 
PD research and understanding.  As with the relentless 
pursuit of the protofibrillar discovery by Dr. Lansbury, all 
methods of research must be exhausted on finding the 
mechanism by which αSyn is able to turn off the ER-
Golgi pathway.  It is feasible that the same lentivirus 
used by Lindquist et al. (2006) to carry the Rab1 gene 
into mammalian neurons in their experiments could be 
re-configured to enter the cells of PD patients and re-
establish traffic between the ER and Golgi.  If this is, in 
fact, the reason these cells are dying, one of the most 
prevalent and debilitating neurodegenerative diseases 
could be cured. 
    
Note: Eukaryon is published by students at Lake Forest 
College, who are solely responsible for its content. The 
views expressed in Eukaryon do not necessarily reflect 
those of the College. Articles published within Eukaryon 
should not be cited in bibliographies. Material contained 
herein should be treated as personal communication 
and should be cited as such only with the consent of 
the author.    
 
 
 
References 
 
Caldwell, Sabrina R., Hill, Kathryn J., and Cooper, Antony A., 
Degradation of Endoplasmic Reticulum (ER) Quality Control 
Substrates Requires Transport between the ER and Golgi, 
Journal of Biological Chemistry, volume 276, no. 26, pages 
23296-23303, 2001. 
Fujita, Tukio et al., Fragmentation of Golgi apparatus of nigral 
neurons with α-synuclein-positive inclusions in patients with 
Parkinson’s disease, Acta Neuropathol, volume 112, pages 
261-265, 2006. 
 
Gosavi, Nirmal et al., Golgi Fragmentation Occurs in the Cells 
with Prefibrillar α-Synuclein Aggregates and Precedes the 
Formation of Fibrillar Inclusion, Journal of Biological Chemistry, 
volume 277, no. 50, pages 48984-48992, 2002. 
 
Lansbury, Peter Jr., and Volles, Michael J., Zeroing in on 
the Pathogenic Form of α-Synuclein and Its Mechanism 
of Neurotoxicity in Parkinson’s Disease, Biochemistry, 
volume 42, no. 26, pages 7871-7878, 2003. 
 
Lee, He-Jin et al., Intravesicular Localization and Exocytosis of 
α-Synuclein and its Aggregates, Journal of Neuroscience, 
volume 25, issue 25, pages 6016-6024, 2005. 
 
Lindquist, Susan et al., α-Synuclein Blocks ER-Golgi Traffic and 
Rab1 Rescues Neuron Loss in Parkinson’s Models, Science, 
volume 313, issue 5785, pages 324-328, Epub 2006. 
 
McCracken, A., and Brodsky, J., Recognition and Delivery of 
ERAD Substrates to the Proteasome and Alternative Paths for 
Cell Survival, CTMI, volume 300, pages 17-40, 2006. 
 
PD Statistics Provided by the National Parkinson Foundation.  
Retrieved on 2 September 2006 from 
http://www.parkinson.org/site/pp.asp?c=9dJFJLPwB&b=71354. 
 
Purves, Dale et al., Neuroscience 3rd Edition, Sinauer 
Associates Inc., Maryland, 2004. 
 
Figure 1:  Rab1 enhances ER-Golgi vesicular binding affinity. This diagram portrays the ER-Golgi junction and the vesicular 
transport that occurs between the two organelles.  (+) indicates the presence of the indicated protein and (-) indicates its absence.  
The black circles represent a vesicle full of cargo (ex. CPY), the red circles αSyn, and the blue cross Ypt1p/Rab1.  αSyn blocks ER-
Golgi traffic and leads to cell death (far right).  Overexpression of Ypt1p/Rab1 rescues cells from atrophy by increasing the affinity of 
the vesicle for the Golgi (middle).  Vesicular transport without αSyn is shown on the left. 
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